Doug Drysdale, CEO of Cybin opens up to Invezz about the benefits of psychedelics based drugs, why psychedelic stocks are struggling and how Big Pharma may soon get involved in the sector.

Trump's tariff hike mirrors the 1930 Smoot-Hawley Tariff Act, which exacerbated the Great Depression and led to a major shift ...

"We’re always chasing the future, and as a result, we never get to feel proud and satisfied with what we have achieved or ...

Benner Cycle predicts a 2026 market peak; retail investors rally behind it amid economic instability and rising recession fears.

the CEOs exhibited vocal markers consistent with depression, according to research led by Nargess Golshan, assistant professor of accounting at the Kelley School of Business at IU Bloomington.